- Report
- November 2025
- 150 Pages
Global
From €5350EUR$5,950USD£4,586GBP
- Report
- February 2026
- 250 Pages
Global
From €4037EUR$4,490USD£3,461GBP
- Report
- May 2026
- 150 Pages
Global
From €2427EUR$2,699USD£2,080GBP
- Report
- June 2026
- 150 Pages
Global
From €4271EUR$4,750USD£3,661GBP
- Report
- April 2026
- 160 Pages
Global
From €2985EUR$3,320USD£2,559GBP
€3731EUR$4,150USD£3,199GBP
- Report
- August 2025
- 150 Pages
Global
From €4361EUR$4,850USD£3,738GBP
- Report
- November 2025
- 150 Pages
United States
From €3551EUR$3,950USD£3,045GBP
- Report
- August 2026
- 487 Pages
Global
From €5260EUR$5,850USD£4,509GBP
- Report
- August 2026
- 563 Pages
Global
From €5260EUR$5,850USD£4,509GBP
- Report
- November 2025
- 185 Pages
Global
From €4046EUR$4,500USD£3,468GBP
- Drug Pipelines
- May 2026
- 150 Pages
Global
From €2508EUR$2,789USD£2,150GBP
- Report
- April 2026
- 160 Pages
Global
From €2985EUR$3,320USD£2,559GBP
€3731EUR$4,150USD£3,199GBP
- Report
- March 2026
- 135 Pages
Global
From €4361EUR$4,850USD£3,738GBP
- Report
- June 2026
- 190 Pages
Global
From €3187EUR$3,545USD£2,732GBP
€3542EUR$3,939USD£3,036GBP
- Report
- February 2026
- 250 Pages
Global
From €4037EUR$4,490USD£3,461GBP
- Report
- July 2025
- 120 Pages
Global
From €5350EUR$5,950USD£4,586GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1349EUR$1,500USD£1,156GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1798EUR$2,000USD£1,542GBP
- Report
- June 2024
- 200 Pages
Global
From €7148EUR$7,950USD£6,128GBP
- Report
- June 2024
- 200 Pages
Global
From €7148EUR$7,950USD£6,128GBP

The Urinary Incontinence Drug market is a subset of the Urological Disorders Drugs market, which includes drugs used to treat a variety of conditions related to the urinary system. Urinary Incontinence Drugs are used to treat the involuntary leakage of urine, which can be caused by a variety of conditions, including overactive bladder, stress incontinence, and urge incontinence. These drugs can be administered orally, topically, or through injections. Commonly used drugs include anticholinergics, beta-3 agonists, and alpha-blockers.
Some of the companies in the Urinary Incontinence Drug market include Allergan, Astellas Pharma, Pfizer, Merck, and Sanofi. Show Less Read more